当前位置:首页 - 行情中心 - 海森药业(001367) - 财务分析 - 现金流量表

海森药业

(001367)

  

流通市值:28.26亿  总市值:35.39亿
流通股本:1.22亿   总股本:1.52亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金93,936,790.22394,681,831.03295,538,019.6201,941,423.47
  收到的税费返还4,005,696.1812,593,342.986,633,093.623,018,544.23
  收到其他与经营活动有关的现金1,192,607.8615,588,954.548,512,647.725,288,700.97
  经营活动现金流入小计99,135,094.26422,864,128.55310,683,760.94210,248,668.67
  购买商品、接受劳务支付的现金30,956,838.8108,631,921.36104,370,799.0965,119,280.88
  支付给职工以及为职工支付的现金27,537,221.9480,588,504.9161,552,094.2243,101,401.8
  支付的各项税费9,730,403.3621,525,818.4819,455,575.8717,262,659.14
  支付其他与经营活动有关的现金4,626,084.8934,664,292.7818,101,074.5410,438,693.27
  经营活动现金流出小计72,850,548.99245,410,537.53203,479,543.72135,922,035.09
  经营活动产生的现金流量净额26,284,545.27177,453,591.02107,204,217.2274,326,633.58
二、投资活动产生的现金流量:
  收回投资收到的现金652,968,525.411,943,017,801.561,260,661,019.51338,568,726.36
  投资活动现金流入小计652,968,525.411,943,017,801.561,260,661,019.51338,568,726.36
  购建固定资产、无形资产和其他长期资产支付的现金9,032,126.83152,263,155.87138,557,108.37122,116,302.59
  投资支付的现金770,000,0002,088,000,0001,748,000,000828,000,000
  投资活动现金流出小计779,032,126.832,240,263,155.871,886,557,108.37950,116,302.59
  投资活动产生的现金流量净额-126,063,601.42-297,245,354.31-625,896,088.86-611,547,576.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金-3,580,726.83,580,726.8-
  筹资活动现金流入平衡项目-00-
  筹资活动现金流入小计-3,580,726.83,580,726.8-
  分配股利、利润或偿付利息支付的现金-17,451,01017,451,01017,451,010
  支付其他与筹资活动有关的现金-1,723,765273,735-
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-19,174,77517,724,74517,451,010
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--15,594,048.2-14,144,018.2-17,451,010
四、汇率变动对现金及现金等价物的影响-450,359.4912,993.881,242,771.261,166,299.42
五、现金及现金等价物净增加额-100,229,415.55-134,472,817.61-531,593,118.58-553,505,653.23
  加:期初现金及现金等价物余额900,009,294.671,034,482,112.281,034,482,112.281,034,482,112.28
  期末现金及现金等价物余额799,779,879.12900,009,294.67502,888,993.7480,976,459.05
补充资料:
  净利润-135,879,665.78-60,794,153.31
  资产减值准备-3,451,459.11-705,117.39
  固定资产和投资性房地产折旧-19,744,823.14-7,994,994.74
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-19,744,823.14-7,994,994.74
  无形资产摊销-2,310,675.37-900,732.96
  长期待摊费用摊销-468,106.08-228,858.13
  固定资产报废损失-400,279.01-204,663.86
  公允价值变动损失--1,695,000--
  财务费用-397,911.99--886,147.78
  投资损失--5,017,801.56--568,726.36
  递延所得税-1,656,928.64--1,909,436.41
  其中:递延所得税资产减少--565,390.76--
    递延所得税负债增加-2,222,319.4--1,909,436.41
  存货的减少--3,047,456.02-297,544.59
  经营性应收项目的减少--16,481,382.23-7,486,547.03
  经营性应付项目的增加-17,169,393.06--1,513,438.19
  其他-20,711,020.83--161,862.15
  现金的期末余额-820,009,294.67-480,976,459.05
  减:现金的期初余额-1,034,482,112.28-1,034,482,112.28
  加:现金等价物的期末余额-80,000,000--
  现金及现金等价物的净增加额--134,472,817.61--553,505,653.23
公告日期2026-04-282026-03-262025-10-222025-08-15
审计意见(境内)标准无保留意见
TOP↑